The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Exelon's revenues will expand 10.5% and EPS will wither -20.0%.
The average estimate for revenue is $5.34 billion. On the bottom line, the average EPS estimate is $0.68.
Last quarter, Exelon tallied revenue of $6.44 billion. GAAP reported sales were 44% higher than the prior-year quarter's $4.36 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.64. GAAP EPS of $0.44 for Q4 were 52% lower than the prior-year quarter's $0.91 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 23.2%, much worse than the prior-year quarter. Operating margin was 10.7%, much worse than the prior-year quarter. Net margin was 6.0%, 790 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $24.71 billion. The average EPS estimate is $2.50.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 1,888 members out of 1,949 rating the stock outperform, and 61 members rating it underperform. Among 441 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 426 give Exelon a green thumbs-up, and 15 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Exelon is hold, with an average price target of $35.13.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Exelon. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Exelon to My Watchlist.